4//SEC Filing
PRICE MICHAEL DENNIS 4
Accession 0001209191-20-030621
CIK 0001662524other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 5:41 PM ET
Size
7.0 KB
Accession
0001209191-20-030621
Insider Transaction Report
Form 4
PRICE MICHAEL DENNIS
Chief Financial Officer
Transactions
- Award
Common Stock
2020-05-18+50,000→ 50,000 total - Award
Stock Option (right to buy)
2020-05-18+300,000→ 300,000 totalExercise: $14.78Exp: 2030-05-17→ Common Stock (300,000 underlying)
Footnotes (2)
- [F1]Represents restricted stock unit award granted under the Issuer's 2015 Equity Incentive Plan.
- [F2]The shares vest as follows: 1/4th of the shares vest one year after May 18, 2020; 1/48th of the shares vest monthly thereafter over the next three years.
Documents
Issuer
AKCEA THERAPEUTICS, INC.
CIK 0001662524
Entity typeother
Related Parties
1- filerCIK 0001247313
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 5:41 PM ET
- Size
- 7.0 KB